(Q35569564)

8 August 2017

1 reference

title

Towards molecular diagnosis and targeted therapy of lymphoid malignancies (English)

1 reference

8 August 2017

Adrian Wiestner

1

1 reference

8 August 2017

Louis M. Staudt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582080

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582080

25 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S003719630300194X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

https://api.elsevier.com/content/article/PII:S003719630300194X?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

25 March 2024

published in

Seminars in Hematology

1 reference

8 August 2017

volume

40

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

296-307

1 reference

Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Historical review of lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

1 reference

7 January 2021

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Plasma cell differentiation requires the transcription factor XBP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Signatures of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

1 reference

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

The RB and p53 pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Cell proliferation as a long-term prognostic factor in diffuse large-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Genomic views of the immune system*.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Molecular diagnosis of the hematologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Mantle-cell lymphoma: a population-based clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Autologous hematopoietic stem cell transplantation for mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Evolution of autoantibody responses via somatic hypermutation outside of germinal centers

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

Characterization of a candidate bcl-1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2900194-X

7 January 2021

BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas

7

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma

25 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma

25 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

Pounding in the neck in supraventricular tachycardia

25 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line

25 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation

25 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma

25 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/S0037-1963(03)00194-X

25 March 2024

Identifiers

1 reference

8 August 2017

1 reference